Quick Answer
Omada Health, Inc. reported Diluted EPS of $0.35 per share (loss) for fiscal year 2025.
Omada Health, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.35 | +94.3% |
| 2024 | -$6.11 | +35.8% |
| 2023 | -$9.52 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.06 | +94.9% | +75.0% |
| June 30, 2025 | -$0.24 | +82.9% | +79.7% |
| September 30, 2024 | -$1.18 | — | +15.7% |
| June 30, 2024 | -$1.40 | — | — |
- Omada Health, Inc. showed an increase of +94.3% in Diluted EPS compared to the prior fiscal year.
- Over the 2023–2025 period, Omada Health, Inc.’s diluted eps has grown by 96.3% (from $9.52 per share (loss) to $0.35 per share (loss)).
- The most recent figure is from Omada Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: